RECRUITING

Oxytocin Bolus Versus Infusion in Elective Cesarean Section"

Talk to us

Conditions

Elective Cesarean SectionOxytocin, bolus, infusion

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Bolus administration of oxytocin is superior to infusion in time to achieving adequate uterine tone.

Official Title

Randomized Double-Blinded Clinical Trial of Oxytocin Bolus Versus Infusion in Elective Cesarean Section

Quick Facts

Study Start:2022-03-15
Study Completion:2024-12-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05236985

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Parturients between the ages of 18 to 45 with singleton pregnancies
  2. * Undergoing elective cesarean section under spinal anesthesia
  3. * American Society of Anesthesia (ASA) physical status class I or II
  4. * Patients must be able to provide written informed consent
  1. * Parturients in labor or ruptured membranes
  2. * Multiple gestation
  3. * Risk factors predisposing to uterine atony (history of placenta previa, preeclampsia, diabetes mellitus macrosomia, hydramnios, bleeding diathesis, uterine fibroids)
  4. * History of uterine atony or postpartum hemorrhage
  5. * History of inherited or acquired coagulation disorders, thrombocytopenia (platelet count \<100), or anemia (hemoglobin \< 8)
  6. * History of allergy to oxytocin
  7. * Patients not alert and orientated to person, place, and date. Patient must have, in the investigator's opinion, the physical and mental capacity to answer survey questions

Contacts and Locations

Study Contact

Tifany E Angelo, DO
CONTACT
631-444-2975
mailto:Tiffany.Angelo@stonybrookmedicine.edu
Ayesha Khan
CONTACT
6314447339
ayesha.khan@stonybrookmedicine.edu

Principal Investigator

Tiffany E Angelo, DO
PRINCIPAL_INVESTIGATOR
Stony Brook University

Study Locations (Sites)

Stony Brook University
Stony Brook, New York, 11794-8167
United States

Collaborators and Investigators

Sponsor: Stony Brook University

  • Tiffany E Angelo, DO, PRINCIPAL_INVESTIGATOR, Stony Brook University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-15
Study Completion Date2024-12-15

Study Record Updates

Study Start Date2022-03-15
Study Completion Date2024-12-15

Terms related to this study

Keywords Provided by Researchers

  • Oxytocin, bolus, infusion

Additional Relevant MeSH Terms

  • Elective Cesarean Section